Savers Value Village, Inc. reports results for the quarter ended June 30 - Earnings Summary
Savers Value Village, Inc. reports results for the quarter ended June 30 - Earnings Summary
Savers Value Village, Inc. SVV.N reported quarterly adjusted earnings of 14 cents per share for the quarter ended June 30, identical to the same quarter last year. The mean expectation of eleven analysts for the quarter was for earnings of 14 cents per share. Wall Street expected results to range from 13 cents to 15 cents per share.
Revenue rose 7.4% to $448.22 million from a year ago; analysts expected $448.97 million.
Savers Value Village, Inc.'s reported EPS for the quarter was 14 cents.
The company reported quarterly net income of $21.63 million.
Savers Value Village, Inc. shares had risen by 8.0% this quarter and gained 16.7% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the miscellaneous specialty retailers peer group is also "buy"
Wall Street's median 12-month price target for Savers Value Village, Inc. is $14.50, about 24.8% above its last closing price of $10.91
This summary was machine generated from LSEG data August 6 at 09:49 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.14 | 0.14 | Met |
Mar. 31 2026 | 0.02 | 0.02 | Met |
Dec. 31 2025 | 0.15 | 0.15 | Met |
Sep. 30 2025 | 0.14 | 0.14 | Met |
Recent news on Savers Value Village
See all newsBrief: Savers Value Village, Inc. Announces Closing Of Upsized Secondary Public Offering Of Common Stock And Concurrent Share Repurchase
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
U.S. STOCKS ON THE MOVE-Nebius Group, Lumentum Holdings
Savers Value Village drops as Ares slices stake in $205 mln secondary offering